Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-15-109532
Filing Date
2015-03-27
Accepted
2015-03-27 16:38:17
Documents
5
Period of Report
2015-03-27

Document Format Files

Seq Description Document Type Size
1 6-K d900229d6k.htm 6-K 9684
2 EX-99.1 d900229dex991.htm EX-99.1 19983
3 EX-99.2 d900229dex992.htm EX-99.2 671293
4 GRAPHIC g900229100.jpg GRAPHIC 21454
5 GRAPHIC g900229ascend.jpg GRAPHIC 4425
  Complete submission text file 0001193125-15-109532.txt   737880
Mailing Address TUBORG BOULEVARD 12 HELLERUP G7 DK-2900
Business Address TUBORG BOULEVARD 12 HELLERUP G7 DK-2900 45 36 94 44 86
Ascendis Pharma A/S (Filer) CIK: 0001612042 (see all company filings)

EIN.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36815 | Film No.: 15731448
SIC: 2834 Pharmaceutical Preparations